337 related articles for article (PubMed ID: 28201724)
1. Distinct Effects of the Cervicovaginal Microbiota and Herpes Simplex Type 2 Infection on Female Genital Tract Immunology.
Shannon B; Gajer P; Yi TJ; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Kaul R
J Infect Dis; 2017 May; 215(9):1366-1375. PubMed ID: 28201724
[TBL] [Abstract][Full Text] [Related]
2. Defining characteristics of genital health in South African adolescent girls and young women at high risk for HIV infection.
Dabee S; Barnabas SL; Lennard KS; Jaumdally SZ; Gamieldien H; Balle C; Happel AU; Murugan BD; Williamson AL; Mkhize N; Dietrich J; Lewis DA; Chiodi F; Hope TJ; Shattock R; Gray G; Bekker LG; Jaspan HB; Passmore JS
PLoS One; 2019; 14(4):e0213975. PubMed ID: 30947260
[TBL] [Abstract][Full Text] [Related]
3. Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.
Joag V; Obila O; Gajer P; Scott MC; Dizzell S; Humphrys M; Shahabi K; Huibner S; Shannon B; Tharao W; Mureithi M; Oyugi J; Kimani J; Kaushic C; Ravel J; Anzala O; Kaul R
Clin Infect Dis; 2019 May; 68(10):1675-1683. PubMed ID: 30407498
[TBL] [Abstract][Full Text] [Related]
4. Impact of Herpes Simplex Virus Type 2 and Human Immunodeficiency Virus Dual Infection on Female Genital Tract Mucosal Immunity and the Vaginal Microbiome.
Keller MJ; Huber A; Espinoza L; Serrano MG; Parikh HI; Buck GA; Gold JA; Wu Y; Wang T; Herold BC
J Infect Dis; 2019 Jul; 220(5):852-861. PubMed ID: 31111902
[TBL] [Abstract][Full Text] [Related]
5. The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.
Mohammadi A; Bagherichimeh S; Perry MC; Fazel A; Tevlin E; Huibner S; Tharao W; Coburn B; Kaul R
Sci Rep; 2020 May; 10(1):8514. PubMed ID: 32444843
[TBL] [Abstract][Full Text] [Related]
6. The Cervicovaginal Microbiota and Its Associations With Human Papillomavirus Detection in HIV-Infected and HIV-Uninfected Women.
Reimers LL; Mehta SD; Massad LS; Burk RD; Xie X; Ravel J; Cohen MH; Palefsky JM; Weber KM; Xue X; Anastos K; Minkoff H; Atrio J; D'Souza G; Ye Q; Colie C; Zolnik CP; Spear GT; Strickler HD
J Infect Dis; 2016 Nov; 214(9):1361-1369. PubMed ID: 27521363
[TBL] [Abstract][Full Text] [Related]
7. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
[TBL] [Abstract][Full Text] [Related]
8. Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota.
Shannon B; Yi TJ; Perusini S; Gajer P; Ma B; Humphrys MS; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Shahabi K; Ravel J; Rebbapragada A; Kaul R
Mucosal Immunol; 2017 Sep; 10(5):1310-1319. PubMed ID: 28120845
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women.
Borgdorff H; Tsivtsivadze E; Verhelst R; Marzorati M; Jurriaans S; Ndayisaba GF; Schuren FH; van de Wijgert JH
ISME J; 2014 Sep; 8(9):1781-93. PubMed ID: 24599071
[TBL] [Abstract][Full Text] [Related]
10. Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract.
Shannon B; Yi TJ; Thomas-Pavanel J; Chieza L; Janakiram P; Saunders M; Tharao W; Huibner S; Remis R; Rebbapragada A; Kaul R
J Immunol; 2014 Jun; 192(11):5074-82. PubMed ID: 24760150
[TBL] [Abstract][Full Text] [Related]
11. Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition in Young South African Women.
Gosmann C; Anahtar MN; Handley SA; Farcasanu M; Abu-Ali G; Bowman BA; Padavattan N; Desai C; Droit L; Moodley A; Dong M; Chen Y; Ismail N; Ndung'u T; Ghebremichael MS; Wesemann DR; Mitchell C; Dong KL; Huttenhower C; Walker BD; Virgin HW; Kwon DS
Immunity; 2017 Jan; 46(1):29-37. PubMed ID: 28087240
[TBL] [Abstract][Full Text] [Related]
12. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
[TBL] [Abstract][Full Text] [Related]
13. The Influence of Cervicovaginal Microbiota on Mucosal Immunity and Prophylaxis in the Battle against HIV.
Farcasanu M; Kwon DS
Curr HIV/AIDS Rep; 2018 Feb; 15(1):30-38. PubMed ID: 29516267
[TBL] [Abstract][Full Text] [Related]
14. Secretory IgA antibody in cervicovaginal secretions from women with genital infection due to herpes simplex virus.
Merriman H; Woods S; Winter C; Fahnlander A; Corey L
J Infect Dis; 1984 Apr; 149(4):505-10. PubMed ID: 6327834
[TBL] [Abstract][Full Text] [Related]
15. Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women.
Mitchell CM; Haick A; Nkwopara E; Garcia R; Rendi M; Agnew K; Fredricks DN; Eschenbach D
Am J Obstet Gynecol; 2015 May; 212(5):611.e1-9. PubMed ID: 25524398
[TBL] [Abstract][Full Text] [Related]
16. Valacyclovir therapy does not reverse herpes-associated alterations in cervical immunology: a randomized, placebo-controlled crossover trial.
Yi TJ; Shannon B; Chieza L; Su D; Saunders M; Tharao W; Huibner S; Remis R; Raboud J; Kaul R
J Infect Dis; 2014 Sep; 210(5):708-12. PubMed ID: 24664172
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
[TBL] [Abstract][Full Text] [Related]
18. Association between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.
Nené NR; Reisel D; Leimbach A; Franchi D; Jones A; Evans I; Knapp S; Ryan A; Ghazali S; Timms JF; Paprotka T; Bjørge L; Zikan M; Cibula D; Colombo N; Widschwendter M
Lancet Oncol; 2019 Aug; 20(8):1171-1182. PubMed ID: 31300207
[TBL] [Abstract][Full Text] [Related]
19. Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection.
John M; Keller MJ; Fam EH; Cheshenko N; Hogarty K; Kasowitz A; Wallenstein S; Carlucci MJ; Tuyama AC; Lu W; Klotman ME; Lehrer RI; Herold BC
J Infect Dis; 2005 Nov; 192(10):1731-40. PubMed ID: 16235171
[TBL] [Abstract][Full Text] [Related]
20. Deciphering the Role of Mucosal Immune Responses and the Cervicovaginal Microbiome in Resistance to HIV Infection in HIV-Exposed Seronegative (HESN) Women.
Munusamy Ponnan S; Thiruvengadam K; Tellapragada C; Ambikan AT; Narayanan A; Kathirvel S; Mathayan M; Shankar J; Rajaraman A; Afshan Amanulla M; Dinesha TR; Poongulali S; Saravanan S; Murugavel KG; Swaminathan S; Velu V; Shacklett B; Neogi U; Hanna LE
Microbiol Spectr; 2021 Oct; 9(2):e0047021. PubMed ID: 34704803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
